D
DAC
Full name: Drug Affinity Complex
A peptide modification technology that introduces a reactive maleimidopropionic acid (MPA) group into the peptide chain, enabling covalent binding to cysteine-34 of albumin in the bloodstream. Used in CJC-1295 DAC to extend half-life from minutes to approximately one week without significantly altering the GHRH-receptor binding profile.